Opportunity
Alberta Purchasing #AB-2026-07098
Award for Off-Patent Oncology Pharmaceuticals
Posted
October 23, 2026
Identifier
AB-2026-07098
NAICS
325412, 424210
HealthPRO Canada awarded a procurement for off-patent oncology pharmaceuticals for healthcare institutions. - Buyer: HealthPRO Procurement Services Inc. (HealthPRO Canada); no specific department, sub-agency, or office is identified. - Awarded pharmaceutical manufacturers: Apotex Inc., Dr. Reddy's Laboratories Canada Inc., and Auro Pharma Inc. - Products: Off-patent oncology pharmaceuticals and related products. The notice does not specify drug names, part numbers, or quantities. - Award amounts: Apotex Inc. — 876; Dr. Reddy's Laboratories Canada Inc. — 817; Auro Pharma Inc. — 0 and 1,094,825. The notice states a total award value of 1,096,518; it does not specify the currency. - Notable requirements: Products are primarily intended for use by healthcare institutions. No additional product specifications or quantities are provided.
Description
HealthPRO Procurement Services Inc. posted an award notice for its June 2026 Market Response RFP for off-patent oncology items. The procurement covers oncology pharmaceutical and related products primarily used by healthcare institutions. The notice lists awarded suppliers and a total actual award value of 1,096,518. Secure access to the opportunity is available by contacting rfpinquiriesph@healthprocanada.com; future addendums and amendments will be posted on Euna, previously Bonfire.